SCHEMBL21888079

SCHEMBL21888079

NC(=S)c1ncn([C@H]2CC[C@@H](COP(=O)(O)O)O2)c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATIC P31939 2/20 0.50
FBP1 P09467 2/20 0.50
DNPH1 O43598 1/20 0.37
PRKAB2 O43741 1/20 0.37
TRPM2 O94759 1/20 0.37
LDHA P00338 1/20 0.37
ADRB2 P07550 1/20 0.37
SRC P12931 1/20 0.37
ADORA1 P30542 1/20 0.37
P2RY2 P41231 1/20 0.37
P2RY1 P47900 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PDE4D Q08499 1/20 0.37
KCNH2 Q12809 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PDE3A Q14432 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888890 1.00 ATIC (0.50) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL21888122 0.91 ATIC (0.61) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL21888087 0.90 FBP1 (0.49) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL21887926 0.82 ATIC (0.50) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL13787115 0.81 ATIC (0.49) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL21888253 0.81 ATIC (0.57) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL14605289 0.79 DNMT1 (0.51) ATICFBP1DNPH1PRKAB2TRPM2
SCHEMBL20959779 0.76 P2RY1 (0.62) FBP1DNPH1PRKAB2TRPM2LDHA
SCHEMBL20225051 0.76 P2RY1 (0.62) FBP1DNPH1PRKAB2TRPM2LDHA
SCHEMBL20225019 0.76 P2RY1 (0.62) FBP1DNPH1PRKAB2TRPM2LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020072931-A2 PRE-ACTIVATED NUCLEOSIDE IMPDH INHIBITORS AS ANTI-INFECTIVE DRUGS OCTAGON THERAPEUTICS INC. (US) 2020-04-09 WO disclosed